BOSTON, March 7, 2011 /PRNewswire/ — Through various
presentations to be delivered at the Drug Information Association
(DIA) 23rd Annual EuroMeeting, being held March 28-30, 2011 in
Geneva, Switzerland, experts from PAREXEL International
Corporation (Nasdaq:
PRXL), a leading global biopharmaceutical services provider,
will address advanced approaches to help the biopharmaceutical
industry meet demands of a changing global marketplace.
Experts from PAREXEL will be available at Stands 1050, 1052,
1151, and 1153 in the exhibit hall to discuss how the Company
can help biopharmaceutical companies improve early-stage decisions,
accelerate pivotal trials, reach new markets, and leverage
technologies for increased operational quality and efficiency.
PAREXEL experts will discuss new operational models,
supported by technology, to help its clients achieve greater
benefits and speed development.
The DIA EuroMeeting program features the following presentations
by PAREXEL experts, which address the benefits of combined clinical
and technology expertise to enable more effective information flow
and improved data access for greater visibility into trials –
and ultimately, better decision making:
Tuesday, March 29
Session 1, 9:00: Use of Electronic Health Records for
Clinical Research, Isabelle de Zegher, Worldwide Senior Director
Technology Integration and Data Standards
Wednesday, March 30
Session 5, 9:00: How to Go Effectively from Data Collection
in CDASH to Submission in SDTM: The need for an eCRF library,
Isabelle de Zegher, Worldwide Senior Director Technology
Integration & Data StandardsSession 6, 11:00: Using
Technology to Improve the Clinical Trial Process, Liz Love, Product
ManagerSession 8, 16:00: Simplicity (for sites) is the
Ultim
‘/>”/>
SOURCE
